137 related articles for article (PubMed ID: 6204670)
21. Internalization and acidification of surface HLA-DR molecules by epidermal Langerhans cells: a paradigm for antigen processing.
Girolomoni G; Cruz PD; Bergstresser PR
J Invest Dermatol; 1990 Jun; 94(6):753-60. PubMed ID: 2355180
[TBL] [Abstract][Full Text] [Related]
22. Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man.
Faure M; Frappaz A; Schmitt D; Dezutter-Dambuyant C; Thivolet J
Cell Immunol; 1984 Feb; 83(2):271-9. PubMed ID: 6229342
[TBL] [Abstract][Full Text] [Related]
23. Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis.
Crivellato E; Damiani D; Mallardi F
Acta Histochem; 1990; 88(1):59-64. PubMed ID: 2113342
[TBL] [Abstract][Full Text] [Related]
24. In vitro studies of epidermal antigen-presenting cells. The mixed skin lymphocyte reaction: an in vitro model for the generation of alloreactive cytotoxic T cells by human epidermal cells.
Faure M; Schmitt D; Dezutter-Dambuyant C; Frappaz A; Gaucherand M; Thivolet J
Br J Dermatol; 1984 Jul; 111 Suppl 27():11-7. PubMed ID: 6234919
[TBL] [Abstract][Full Text] [Related]
25. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.
Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK
J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218
[TBL] [Abstract][Full Text] [Related]
26. Normal counterparts of hairy cells and B-prolymphocytes in the peripheral blood. An ultrastructural study with monoclonal antibodies and the immunogold method.
Robinson DS; Posnett DN; Zola H; Catovsky D
Leuk Res; 1985; 9(3):335-48. PubMed ID: 2582211
[TBL] [Abstract][Full Text] [Related]
27. Ontogeny of Langerhans cells in human embryonic and fetal skin: expression of HLA-DR and OKT-6 determinants.
Foster CA; Holbrook KA; Farr AG
J Invest Dermatol; 1986 Mar; 86(3):240-3. PubMed ID: 2427603
[TBL] [Abstract][Full Text] [Related]
28. HLA-DR antigen expression on the keratinocyte surface in dermatoses characterized by lymphocytic exocytosis (e.g. pityriasis rosea).
Aiba S; Tagami H
Br J Dermatol; 1984 Sep; 111(3):285-94. PubMed ID: 6206885
[TBL] [Abstract][Full Text] [Related]
29. Expression of HLA-DR antigen in skin from patients with psoriasis.
Morhenn VB; Abel EA; Mahrle G
J Invest Dermatol; 1982 Feb; 78(2):165-8. PubMed ID: 6173446
[TBL] [Abstract][Full Text] [Related]
30. Use of the fluorescence-activated cell sorter to quantitate and enrich for subpopulations of human skin cells.
Morhenn VB; Benike CJ; Charron DJ; Cox A; Mahrle G; Wood GS; Engleman EG
J Invest Dermatol; 1982 Nov; 79(5):277-82. PubMed ID: 6752290
[TBL] [Abstract][Full Text] [Related]
31. Differing cell surface distribution of human leukocyte antigen-DR molecules on epidermal Langerhans cells and eccrine duct cells.
Imayama S; Yashima Y; Hori Y
J Histochem Cytochem; 1992 Aug; 40(8):1191-6. PubMed ID: 1619281
[TBL] [Abstract][Full Text] [Related]
32. Detection of distinct subpopulations of Langerhans cells by flow cytometry and sorting.
Vaigot P; Czernielewski J; Prunieras M
Cytometry; 1985 Sep; 6(5):422-7. PubMed ID: 2931262
[TBL] [Abstract][Full Text] [Related]
33. [Expression of class II HLA antigens (HLA-DR, DQW1, DQW3) in normal skin and cutaneous pathology].
Gomes M; Schmitt D; Dezutter-Dambuyant C; Capra JD; Thivolet J
Pathol Biol (Paris); 1986 Mar; 34(3):157-64. PubMed ID: 3517784
[TBL] [Abstract][Full Text] [Related]
34. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
[TBL] [Abstract][Full Text] [Related]
35. HLA-D and -DR antigens on human amniotic fluid cells. II. Heterogeneous expression of HLA-DR and other cell surface markers.
Kreeb G; Valentine-Thon E; Krumbacher K; Grosse-Wilde H; Passarge E
Tissue Antigens; 1984 Jan; 23(1):61-7. PubMed ID: 6367138
[TBL] [Abstract][Full Text] [Related]
36. Loss of HLA-DR expression by human epidermal cells after growth in culture.
Hefton JM; Amberson JB; Biozes DG; Weksler ME
J Invest Dermatol; 1984 Jul; 83(1):48-50. PubMed ID: 6376639
[TBL] [Abstract][Full Text] [Related]
37. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
[TBL] [Abstract][Full Text] [Related]
38. Comparative phenotypic and ultrastructural characteristics of OKT6-positive cells in normal peripheral blood (adult and infant), in cord blood and in epidermis.
Dezutter-Dambuyant C; Schmitt D; Thivolet J
Dev Comp Immunol; 1986; 10(4):571-84. PubMed ID: 3817252
[TBL] [Abstract][Full Text] [Related]
39. Methods in laboratory investigation. Immunoelectron microscopic methods for demonstration of antigens on normal human melanocytes and other epidermal cells.
van Duinen SG; Mauw BJ; de Graaff-Reitsma CB; Ruiter DJ
Lab Invest; 1984 Jun; 50(6):733-41. PubMed ID: 6427521
[TBL] [Abstract][Full Text] [Related]
40. Internalization of surface HLA-DR molecules by human epidermal Langerhans cells: analysis by flow cytometry and confocal microscopy.
Rizova H; Carayon P; Michel L; Barbier A; Lacheretz F; Dubertret L
Cell Biol Toxicol; 1994 Dec; 10(5-6):367-73. PubMed ID: 7697498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
